MTX652, a Novel Selective USP30 Inhibitor for the Treatment of AKI: Phase 1 Results in Healthy Subjects and Model-Driven Human Efficacious Dose Projections: TH-OR93

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2023-11, Vol.34 (11S), p.27-27
Main Authors: Aceves, Pau, Thompson, Paul W., Jones, Natalie, Nurbhai, Suhail
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20233411S127a